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Complete stereocontrol in formation of 
macrocyclic lanthanide complexes: direct 
formation of enantiopure systems for circularly 
polarised luminescence applications† 
Nicholas H. Evans,a Rachel Carr,a Martina Delbianco,a Robert Pal,a Dmitry 
S. Yufita and David Parker*,a  
A single C-substitution of the 1, 4, 7-triazacyclononane ring induces formation of single 
enantiomers of Eu(III) complexes with nonadentate N 6O 3 ligands. The absolute configuration of 
each complex is determined by the stereogenicity of the C-substituent, revealed by comparison 
of the sign and sequence of CPL transitions for a series of complexes. 
 
Introduction 
Complexes of the most emissive lanthanides (Eu, Tb) have 
been studied extensively for luminescence applications, and 
now investigations into the circularly polarised luminescence 
(CPL) of chiral lanthanide complexes are increasingly being 
reported. Given the omnipresence of chirality, CPL can provide 
a rich source of information on local asymmetry.1 
 In working towards the development of well-defined 
chemical probes that are able to signal changes in the local 
chiral environment reversibly by CPL, the design and synthesis 
of highly emissive enantiopure species is key. However, the 
selective formation of enantiomerically pure metal complexes 
has been a considerable challenge to the coordination chemist. 
A highly logical means of achieving this aim is by transmitting 
the chiral information from one or more enantiopure ligands to 
the metal centre.2 This approach has been explored in the 
synthesis of several lanthanide-containing systems, including 
helicates3 and complexes derived from the cyclen framework.4-6
 Ligands based on triazacyclononane macrocycles represent 
excellent choices for the generation of thermodynamically and 
kinetically stable metal complexes.7 The ring nitrogens act 
primarily as donor atoms and are readily elaborated to allow for 
additional ligation. Six coordinate phosphinate 
triazacyclononane complexes of In(III) and Ga(III) which exist 
as RRR/SSS enantiomers have been known for some time.8 Of 
particular note is control of complex configuration by the 
incorporation of a single C-substitution into the ring system of a 
hexadentate copper-containing NOTA-derived complex.9 Nine 
coordinate tris-carboxylate triazacyclononane complexes of 
Ln(III) ions have been reported by Mazzanti and co-workers, 
and were shown in the solid state to exist in tri-capped trigonal 
prismatic coordination geometry, present as Λ-(δδδ) and  
 
Fig. 1 The stereoisomers of trispyridylphosphinate triazacyclononane complexes 
[LnL1-2]. R=Ph, Me, where ∆ and δ refer to positive NCCN py  and NCCN (ring) 
torsion angles. 
∆-(λλλ) enantiomers.10 Very recently, we reported the 
preparation of the Eu and Tb complexes of 
trispyridylphosphinate triazacyclononane [LnL1-2] (Figure 
1).11, 12 These species were prepared as a racemate of their two 
enantiomers: RRR-Λ-(δδδ) and SSS-∆-(λλλ),13 hence requiring 
resolution by chiral HPLC to allow for direct CPL analysis. In 
this work, we have set out to bias formation of a single complex 
enantiomer, by the inclusion of a stereogenic centre on the 
triazacyclononane ring. 
Results and discussion 
Synthesis and characterisation of complexes 
The synthesis of the europium complexes [EuL3-9] studied is 
presented in Scheme 1 (see also: ESI†). The substituted 9-N3 
macrocycle rings for L4-7, 9 were prepared following established 
methods, in which the substituted chiral centre derives from the 
alkyl esters of α-amino acids.14, 15 The ethyl esters of ligands 
L3-7 were formed by alkylation of the 9-N3 ring with three  
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Scheme 1 Synthesis of [EuL3-9]. See experimental section for yields. 
equivalents of the methyl phosphinate mesylate 1a or 1b. 
Pyridyl bromine substituents have been included to allow for 
subsequent metal catalysed C-C or C-N functionalization. In 
addition, the methyl esters of the carboxylate ligands L8-9 were 
prepared to allow for comparison. Basic ester hydrolysis 
yielded L3-9, each of which was complexed with Eu(III). 
 Complexes [EuL3-9] were characterised by 1H and 31P NMR 
and electrospray MS (Figure 2 and ESI†). The non-equivalence 
of the P atoms in the substituted phosphinate complexes 
[EuL4-7] is most clearly revealed by the presence of three peaks 
in the 31P NMR spectra (Figure 2d). 
 
Fig. 2 NMR spectra: (a) 1H [EuL3], (b) 1H [EuL5-S], (c) 31P [EuL3], (d) 31P [EuL5-S]. 
(9.4 T, CD 3 OD, 295K). 
 Fluorescence lifetimes for [EuL3] were recorded in H2O 
(τ = 1.23 s) and D2O (τ = 1.52 s). Using these values, the 
complex hydration state was calculated to be zero, consistent 
with the ligand acting as a nonadentate donor for the Eu(III) 
ion. 
 
Fig. 3 Crystal structure of [EuL3]. SSS-∆-(λλλ) enantiomer depicted. 
 Subsequently, single crystals of [EuL3] suitable for X-ray 
crystallographic determination were grown by slow evaporation 
of a MeOH solution of the racemate of the complex. The 
structure reveals a nine coordinate complex with C3 symmetry, 
in agreement with the solution phase characterisation (Figure 
3). The mean bond distances and NCCN and NCCNpy torsional 
angles are almost identical to those previously reported for a 
tris(phenyl phosphinate) complex, [EuL1] (Table 1). 
Table 1: Selected mean bond distances (Å ± 0.02) and torsional angles (° ± 
1.0) for complexes [EuL3] and [EuL1]11.a 
 Eu - O Eu - N Eu - Npy NCCN NCCNpy 
 
[EuL3] 2.33 2.69 2.65 - 48 + 35.5 
[EuL1] 2.33 2.68 2.66 - 47 + 33 
a Signs of torsional angles are reported for the SSS-∆-(λλλ) enantiomer. 
Stereochemistry and CPL of complexes  
 The racemates of the unsubstituted complexes [EuL3] and 
[EuL8] were separated by chiral HPLC. For the C-substituted 
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complexes, chiral HPLC (CHIRALPAK-IC or ID, MeOH) 
verified formation of a single stereoisomer, with an 
enantiomeric excess > 96 % being observed in the case of 
[EuL5-R].16 The resolved enantiomers of the methyl 
phosphinate complex [EuL3] racemise slowly when heated to 
60 °C in H2O, with a half-life of 185 (± 20) h determined by 
observing the % e. e. change using chiral HPLC (ESI†). The 
carboxylate complex [EuL8] racemises in water with a half-life 
of 240 (± 35) h under the same conditions.17 These are 
considerably more stable to racemisation than the frequently 
studied tris-dipicolinate complexes of the Ln(III) cations, e.g. 
Eu tris-dipicolinate, [Eu(dpa)3], has a half-life of 5.1 (± 0.2) ms 
at 60 °C.18 Notably, the methyl substituted carboxylate complex 
[EuL9], showed no loss in enantiopurity after heating to 60 °C 
in H2O for 72 h. 
 Emission and CPL spectra of enantiopure complexes 
[EuL3-9] were recorded (see Figure 4 and ESI†). The CPL 
spectra of the two enantiomers of the [EuL3] are mirror images 
(Fig. 4a, b). The methyl phosphinate complexes derived from 
the natural stereoisomer (i.e. S enantiomer) of the amino acid 
have the same spectral sign as for RRR-Λ-(δδδ) enantiomer of 
[EuL3], while for those derived from the unnatural 
stereoisomer had the opposite sign (see ESI†).19 Large values 
for the emission dissymmetry factor, (gem = 2(IL-IR)/(IL+IR)) 
were observed in the ∆J = 1 band (see ESI†), specifically 
gem(591.5 nm) = ± 0.10 for enantiopure samples of [EuL3-5], and 
generally there were no significant differences in the 
appearance of the CPL spectra for different substituents R, and 
whether X = Br or H.20, 21 
  
Fig. 4: CPL spectra of ∆-[EuL3] and Λ-[EuL3]. (H2 O, 295 K). 
 The CPL spectra of the two enantiomers of the carboxylate 
complex [EuL8] were also mirror images (ESI†). In 
comparison to the phosphinate complexes there are significant 
changes in sign of the CPL spectra, but with maximum values 
of gem being of the same magnitude in the ∆J = 1 band. As for 
the methyl phosphinate series, C-substitution (e.g. for [EuL9], 
ESI†) had negligible impact on the form and nature of the CPL 
spectra.  
 Rationalisation of the observed stereoselectivity in complex 
formation is provided by consideration of the solid state 
structure of [EuL3]. The enantiomer depicted in Figure 5 is 
SSS-∆-(λλλ), i.e. the configuration observed from complexes 
derived from the unnatural R-amino acid, e.g. [EuL5-R]. 
Inspection reveals that the pro-R hydrogen atom, where the ring 
substituent would reside, is in one of two pseudo-equatorial 
positions (Fig. 5a), the most likely of which (on steric grounds) 
is the one directed away from the three pyridyl arms (Fig. 5b), 
consistent with it occupying a corner (rather than a side) carbon 
atom (Fig. 5c). 
 
Fig. 5 Views of the crystal structure of the SSS-∆-(λλλ) enantiomer of [EuL3] 
illustrating (a) the pseudo-equatorial positions of the pro-R hydrogens on the 
ring, (b) the corner position of the pro-R hydrogen (filled arrow), versus the side 
position of the pro-R hydrogen (dashed arrow) and (c) the ring torsional angles; 
‘corner’ carbons - those that fall between two gauche bonds - are marked with 
asterisks. 
Conclusions 
In summary, complete control of the stereochemistry of 
triazacyclononane based europium complexes has been 
demonstrated by mono-substitution at a single carbon atom on 
the 9-N3 ring, allowing for direct, selective formation of a 
given enantiomer with e.e. > 96 %. Such behaviour allows the 
direct preparation of enantiopure emissive complexes, 
analogues of which can be designed to act as responsive chiral 
probes for application in CPL spectroscopy and microscopy. 
Experimental 
General experimental procedures 
Commerically available reagents were used as received from 
suppliers. Solvents were laboratory grade and dried using an 
appropriate drying agent when required. Reactions requiring 
anhydrous conditions were carried out under an atmosphere of 
dry argon. 
 1H, 13C and 31P NMR spectra were recorded on 
spectrometers operating at magnetic inductions corresponding 
to 1H frequencies at 400, 600 and 700 MHz. Spectra were 
recorded at 295 K in commercially available deuterated 
solvents. ESMS was carried out on a TQD mass spectrometer, 
and accurate masses were recorded on either a LCT Premier or 
Thermo Finnigan LTQ-FT. 
 Reverse phase HPLC purification was performed at 295 K 
on either a Waters or Perkin Elmer system. The Waters system 
consisted of a Waters 575 pump, Waters “System Fluidics 
Organizer”, Waters 2545 “Binary Gradient Module”, Waters 
2767 “Sample Manager”, Waters Fraction Collector III, Waters 
2998 Photodiode Array Detector and Waters 3100 Mass 
Detector. The Perkin Elmer system consisted of a Perkin Elmer 
Series 200 pump, Perkin Elmer Series 200 auto-sampler and 
Perkin Elmer Series 200 UV/Vis detector. XBridge C18 
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columns were used with a flow rate of 1 mL/min (analytical) or 
4.4 mL/min (semi-prep) or 17 mL/min (prep). Solvent systems 
of H2O / CH3OH with 0.1 % HCOOH (gradient elution) were 
used. Chiral HPLC was performed on the Perkin Elmer system 
described above using analytical (4.0 mm × 250 mm) and semi-
prep (10 mm × 250 mm) CHIRALPAK-IC or ID columns. An 
isocratic solvent system of CH3OH was used in all cases. 
Optical spectroscopy 
All samples were contained within quartz cuvettes with a path 
length of 1 cm and a polished base. Measurements were 
recorded at 295 K. Absorbance spectra were measured on a 
Perkin Elmer Lambda 900 UV/Vis/NIR spectrometer using FL 
Winlab software. Emission spectra were recorded on an ISA 
Jobin-Yvon Spex-Fluorolog-3 luminescence spectrometer. 
Lifetime measurements were carried out using a Perkin-Elmer 
LS55 spectrometer using FL Winlab software. The inner sphere 
hydration number (q) for [EuL3] was obtained by measuring 
the excited state lifetime in H2O and D2O. The q value was 
calculated using the equation reported by Clarkson et al.22 
 CPL spectra were recorded on a custom built spectrometer 
consisting of a laser driven light source (Energetiq EQ-99 
LDLS, spectral range 170 to 2100 nm) coupled to an Acton 
SP2150 monochromator (600 g/nm, 300 nm Blaze) that allows 
excitation wavelengths to be selected with a 6 nm FWHM 
band-pass. The collection of the emitted light was facilitated 
(90 º angle set up, 1 cm path length quartz cuvette) by a Lock-
In Amplifier (Hinds Instruments Signaloc 2100) and 
Photoelastic Modulator (Hinds Instruments PEM-90). The 
differentiated light was focused onto an Acton SP2150 
monochromator (1200 g/nm, 500 nm Blaze) equipped with a 
high sensitivity cooled Photo Multiplier Tube (Hamamatsu 
7155-01 red corrected).  Spectra were recorded using a 5 
spectral average sequence in the range of 570-720 nm with 
0.5 nm spectral intervals and 500 µs integration time. The 
recorded CPL spectrum than underwent a 25% Fourier 
transformation smoothening protocol using Origin 8.0 Software 
(Origin Labs) to enhance visual appearance (all calculations 
were carried out using raw spectral data). A schematic figure of 
the CPL instrumentation is provided in the ESI†. 
Crystal structure determination of [EuL3] 
Crystals of [EuL3] suitable for single crystal structure 
determination were grown by slow evaporation of a CH3OH 
solution. The X-ray single crystal data for [EuL3] were 
collected at 120 K on an Agilent Gemini S-Ultra diffractometer 
(graphite monochromator, λMoKα, λ = 0.71073Å) equipped 
with a Cryostream (Oxford Cryosystems) open-flow nitrogen 
cryostat. The structure was solved by direct method and refined 
by full-matrix least squares on F2 for all data using Olex223 and 
SHELXTL24 software. All non-hydrogen atoms were refined 
anisotropically, hydrogen atoms were placed in the calculated 
positions and refined in riding mode. 
Crystal Data for [EuL3]: C27H33Br3N6O6 x 2 (H2O), M 
=1058.23, triclinic, space group P-1, a = 9.8356(4), b = 
12.3427(5), c = 17.2609(8) Å, α =107.259(4), β = 97.936(4), γ 
= 105.863(4)°, V = 1869.30(14) Å3, Z = 2, μ(Mo Kα) = 5.065 
mm-1, Dcalc = 1.880 g/mm3, 21350 reflections measured (5.12 ≤ 
2Θ ≤ 60.00), 10802 unique (R int = 0.0439) were used in all 
calculations. The final R1 was 0.0429 (8528 >2σ (I)) and wR2 
was 0.0918 (all data). CCDC Number: 948247. 
Synthesis of complexes 
The synthesis of phosphinate pyridyl mesylates 1a and 1b have 
been reported elsewhere.11, 25 1, 4, 7-Triazacyclononane 3 (as 
its trihydrochloride salt) was purchased from Sigma-Aldrich. 
Mono-substituted macrocycles 4 - 6 were manufactured 
following a synthetic route presented in the ESI†. Mono-
substituted macrocycle 7 was prepared following an adapted 
literature method.14 The unsubstituted carboxylate pyridyl 
mesylate 2 and carboxylate ligand L8 were prepared following 
adapted literature procedures.10 
 
TRI-ETHYL ESTER OF L3. 1, 4, 7-Triazacyclononane 
trihydrochloride (34 mg, 0.14 mmol) and mesylate 1a (160 mg, 
0.43 mmol) were dissolved in dry CH3CN (10 mL) and K2CO3 
(119 mg, 0.86 mmol) added. The reaction mixture was heated 
under reflux under Ar(g) until all the mesylate starting material 
had been consumed (as monitored by TLC). The reaction was 
then cooled to RT and the solution decanted from excess 
potassium salts. The solvent was removed under reduced 
pressure and the crude material purified by repeated column 
chromatography (alumina, 0 – 2 % CH3OH : CH2Cl2) to give 
the title compound as a colourless oil (101 mg, 74 %). 
δH (CDCl3) 8.08 (3H, dd, 3JH-P 5.8 Hz 4JH-H 1.8 Hz, ArH), 7.87 
(3H, s, ArH), 3.80-4.10 (12H, m, CH2), 2.94 (12H, br s, ring 
H), 1.74 (9H, d, 2JH-P 15 Hz, PCH3), 1.25 (9H, t, 3JH-H 7.1 Hz, 
CH3). δC (CDCl3) 163.2 (para-ArC), 155.5 (d, 1JC-P 153 Hz, 
ortho-ArC), 134.2 (ortho-ArC), 129.2 (d, 2JC-P 22 Hz, meta-
ArC), 128.6 (meta-ArC), 63.7 (CH2), 61.3 (d, 3JC-P 6 Hz, 
CH2CH3), 56.0 (ring C), 16.6 (d, 4JC-P 6 Hz, CH2CH3), 13.5 
(d, 1JC-P 104 Hz, PCH3). δP (CDCl3) 38.4. m/z (HRMS+) 
955.0486 [M + H]+ (C33H49 79Br3N6O6P3 requires 905.0477). 
R f  = 0.44 (alumina, CH2Cl2 : CH3OH 98:2). 
 
THE TRI-ETHYL ESTER OF L4 was prepared in analogous 
manner to L3, using macrocycle 4 (13 mg, 0.090 mmol). The 
crude material was purified by column chromatography 
(alumina, 0 – 2 % CH3OH : CH2Cl2) to give the title 
compound as a colourless oil (36 mg, 41 %). 
δH (CDCl3) 8.05-8.09 (4H, m, ArH), 7.85 (1H, s, ArH), 7.79 
(1H, s, ArH), 2.51-4.14 (23H, multiple CH2 and CH) 1.73-1.78 
(9H, m, PCH3), 1.24-1.29 (9H, m, CH2CH3), 0.95 (3H, d, 3J = 
5.7 Hz, CH3). δP (CDCl3) 38.0. m/z (HRMS+) 969.0625 
[M + H]+ (C34H5179Br3N6O6P3 requires 969.0633). R f = 0.48 
(alumina, CH2Cl2 : CH3OH 98:2). 
 
THE TRI-ETHYL ESTER OF L5-S was prepared in analogous 
manner to L3, using macrocycle 5-S (29 mg, 0.16 mmol). The 
crude material was purified by column chromatography 
(alumina, 0 – 2 % CH3OH : CH2Cl2) to give the title 
compound as a colourless oil (50 mg, 30 %). 
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δH (CDCl3) 8.04-8.11 (4H, m, ArH & ArH), 7.77 (2H, app s, 
ArH), 2.67-4.11 (23H, multiple CH2 and CH), 1.73-1.80 (10H, 
m, PCH3 & CH(CH3)2), 1.24-1.29 (9H, m, CH2CH3), 0.95 
(6H, app t, CH3). δP (CDCl3) 38.1. m/z (HRMS+) 997.0955 
[M + H]+ (C36H55N6O6P379Br3 requires 997.0946). R f = 0.53 
(alumina, CH2Cl2 : CH3OH 98:2). 
 
THE TRI-ETHYL ESTER OF L5-R was prepared in analogous 
manner to L3, using macrocycle 5-R (10 mg, 0.057 mmol). 
Purification of the crude material by column chromatography 
(silica, 0 – 12 % CH3OH : CH2Cl2) yielded the title compound 
as a colourless oil (23 mg, 40 %). NMR and MS data were in 
agreement with the enantiomer tri-ethyl ester of L5-S. 
 
THE TRI-ETHYL ESTER OF L6-S-H was prepared in analogous 
manner to L3, using macrocycle 6-S (94 mg, 0.68 mmol) and 
mesylate 1b (199 mg, 0.68 mmol). The crude material was 
purified by column chromatography (silica, 0 – 9 % CH3OH : 
CH2Cl2) to give the title compound as a yellow oil (66 mg, 
35 %).  
δH (CDCl3) 6.97-8.07 (14H, br m, ArH), 2.45-4.69 (25 H, br m, 
ring CH2, 3 × OCH2 & 4 × CH2), 1.50-1.94 (9H, br m, 3 × 
PCH3), 0.97-1.35 (9H, br m, 3 × OCH2CH3). δP (CDCl3) 39.9.  
m/z (HRMS+) 811.3654 [M + H]+ (C40H58N6O6P3 requires 
811.3631). R f  = 0.25 (silica, CH2Cl2 : CH3OH 90:10).  
 
THE TRI-ETHYL ESTER OF L6-R-H was prepared in analogous 
manner to L6-S-H, using macrocycle 6-R (102 mg, 0.47 mmol). 
The crude material was purified by column chromatography 
(silica, 0 – 25 % CH3OH : CH2Cl2) to give the title compound 
as a yellow oil (91 mg, 24 %). Analytical data were in 
agreement with the enantiomer L6-S-H. 
 
THE TRI-ETHYL ESTER OF L6-S-BR was prepared in analogous 
manner to L3, using macrocycle 6-S (36 mg, 0.16 mmol). The 
crude material was purified by column chromatography (silica, 
0 – 7 % CH3OH : CH2Cl2) to give the title compound as a 
yellow oil (65 mg, 38 %). 
δH (CDCl3) 7.07-8.22 (11H, br m, ArH), 2.36-4.89 (25 H, br m, 
ring CH2, 3 × OCH2, 4 × CH2), 1.54-1.93 (9H, br m, 3 × 
PCH3), 1.12-1.43 (9H, br m, 3 × OCH2CH3). δP (CDCl3) 36.1. 
m/z (HRMS+) 1045.0978 [M + H]+ (C40H55N6O6P3 79Br3 
requires 1045.0946). R f = 0.27 (silica, CH2Cl2 : CH3OH 95:5). 
 
THE TRI-ETHYL ESTER OF L7 was prepared in analogous 
manner to L3, using macrocycle 7 (75 mg, 0.24 mmol). The 
crude material was purified by reverse phase HPLC to give the 
title compound as a yellow oil (65 mg, 25 %). 
δH (CDCl3) 7.82-8.20 (6H, m, ArH), 6.45 (1H, br s, CONH), 
3.87-4.17 (12H, m, PCH2 & NCH2), 2.59-3.23 (13H, m, ring 
CH2 & CH2CONH), 1.76-1.82 (9H, m, PCH3), 1.26-1.76 
(26H, m, PCH2CH3, alkyl chain & cyclohexane CH2/CH). δP 
(CDCl3) 37.8. m/z (HRMS+) 1138.1914 [M + H]+ 
(C44H68 79Br3N7O7P3 requires 1138.1926). R f = 0.32 (silica, 
CH2Cl2 : CH3OH : NH3(aq) 90:10:1). 
 
THE TRI-METHYL ESTER OF L9 was prepared in analogous 
manner to L3, using macrocycle 4 (50 mg, 0.35 mmol) and 
mesylate 2 (257 mg, 1.05 mmol). The crude material was 
purified by repeated column chromatography (silica, 5 – 10 % 
CH3OH : CH2Cl2) to give the title compound as a colourless 
oil (27 mg, 13 %). 
δH (CDCl3) 7.72-8.01 (9H, m, ArH), 3.93-4.21 (15H, m, inc. 
OCH3), 2.75-3.21 (14H, m inc. CH3). m/z (HRMS+) 591.2959 
[M + H]+ (C31H39N6O6 requires 591.2931). R f = 0.12 (silica, 
CH2Cl2 : CH3OH 90:10). 
 
COMPLEX [EUL3]. The tri-ethyl ester of L3 (70 mg, 0.073 
mmol) was dissolved in CH3OH (5 mL) and a solution of 0.1 
M NaOH(aq) (5 mL) added. The mixture was heated to 60 °C. 
After verifying the reaction had gone to completion by 31P 
NMR, the solution was cooled to RT, and the pH adjusted to 6 
using 0.1 M HBr(aq). Eu(NO3)3.5H2O (34 mg, 0.080 mmol) 
was added and the mixture heated to 80 °C for 16 h. The pH 
was raised to 10, precipitated Eu(OH)3 was removed by 
centrifuge. The pH was adjusted to 6 using 0.1 M HBr(aq), and 
the solvent removed under reduced pressure and the product 
purified by column chromatography (silica, 
CH2Cl2 : CH3OH : NH3(aq) 80:20:1) giving the title compound 
as a white solid (74 mg, 98 %). 
δH (400MHz, CD3OD) 8.60 (1H, s, pyH), 7.97 (1H, s, 
pyCHN), 7.12 (1H, s, pyH), 4.36 (1H, s, NCH’eq), 0.54 (3H, s, 
CH3), -0.77 (1H, s, pyCH’N), -1.37 (1H, s, NCH’ax), -2.23 
(1H, s, NCHeq), -5.28 (1H, s, NCHax). δP (162 MHz, CD3OD) 
39.8. m/z (HRMS+) 1020.8512 [M + H]+ 
(C27H34 79Br3N6O6P3151Eu requires 1020.8491). R f = 0.31 
(silica, CH2Cl2 : CH3OH : NH3(aq) 82:15:3). 
A sample of the complex racemate was separated by chiral 
HPLC using an analytical CHIRALPAK-ID column. R t = 
7.4 min & 14.3 min (4.0 mm × 250 mm, CH3OH, 1 mL/min, 
290 K). 
 
COMPLEX [EUL4] was prepared in an analogous manner to 
[EuL3], using the tri-ethyl ester of L4 (24 mg, 0.025 mmol). 
The crude material was purified by column chromatography 
(silica, CH2Cl2 : CH3OH : NH3(aq) 90:10:1), and then reverse 
phase HPLC to obtain the title compound as a white solid 
(3 mg, 11 %). 
δH (400 MHz, CD3OD) 9.57, 8.98, 8.51, 8.15, 7.69, 7.36, 7.14, 
6.74, 6.44, 6.04, 4.63, 2.76, 1.28, 1.12, 0.65, -0.11, -0.82, -1.02, 
-1.50, -1.87, -2.40, -2.79, -5.13, -5.68, -5.79. δP (162 MHz, 
CD3OD) 41.6, 40.4, 38.8. m/z (HRMS+) 1032.8668 [M + H]+ 
(C28H36 79Br3N6O6P3151Eu requires 1032.8658). R f = 0.49 
(silica, CH2Cl2 : CH3OH : NH3(aq) 84:15:1). Due to the partial 
racemisation of the chiral centre (see ESI†), a sample of the 
complex was submitted to chiral HPLC using an analytical 
CHIRALPAK-ID column to separate the two enantiomers. R t = 
(6.9 min &) 13.4 min (4.0 mm × 250 mm, CH3OH, 1 mL/min, 
290 K). 
 
COMPLEX [EUL5-S] was prepared in an analogous manner to 
[EuL3], using the tri-ethyl ester of L5-S (25 mg, 0.025 mmol). 
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The crude material was purified by column chromatography 
(silica, CH2Cl2 : CH3OH : NH3(aq) 90:10:1) to obtain the title 
compound as a white solid (11 mg, 41 %). 
δH (400 MHz, CD3OD) 11.67, 9.47, 8.41, 8.28, 7.82, 7.61, 
7.23, 7.05, 6.52, 5.14, 4.26, 2.70, 1.97, 1.66, 0.94, 0.83, 
0.32, -0.57, -1.15, -2.24, -2.57, -2.82, -3.02, -4.64, -5.96, -6.35. 
δP (162 MHz, CD3OD) 44.4, 41.3, 36.1. m/z (HRMS+) 
1060.8992 [M + H]+ (C30H40N6O6P379Br3151Eu requires 
1060.8971). R f  = 0.10 (silica, CH2Cl2 : CH3OH : NH3(aq) 
90:9:1). Due to the partial racemisation of the chiral centre (see 
ESI†), a sample of the complex was submitted to chiral HPLC 
using an analytical CHIRALPAK-ID column to separate the 
two enantiomers. R t = (7.1 min &) 10.3 min (4.0 mm × 250 
mm, CH3OH, 1 mL/min, 290 K). 
 
COMPLEX [EUL5-R] was prepared in an analogous manner to 
[EuL3], using the tri-ethyl ester of L5-R (7.0 mg, 7.0 µmol). The 
crude material was purified by column chromatography (silica, 
CH2Cl2 : CH3OH : NH3(aq) 90:10:1) to obtain the title 
compound as a white solid (3.5 mg, 47 %). NMR and MS data 
were in agreement with the enantiomer [EuL5-S]. Chiral HPLC 
(ChiralPAK-ID 4.0 mm × 250 mm, CH3OH, 1 mL/min, 290 
K): R t  = 7.0 min. 
 
COMPLEX [EUL6-S-H]. The tri-ethyl ester of L6-S-H (32 mg, 0.04 
mmol) was dissolved in CD3OD (3.5 mL) and a solution of 0.1 
M NaOH in D2O (3.5 mL) was added. The reaction mixture 
was heated for 16 h at 90 oC with stirring. Subsequent removal 
of the solvent under reduced pressure yielded the deprotected 
ligand as a white solid (as verified by ESMS).  
The ligand was dissolved in H2O : CH3OH (4 : 1, 2.5 mL) and 
the pH of the solution adjusted to 5.5 using dilute HCl(aq). 
EuCl3.6H2O (15.9 mg, 0.04 mmol) was added and the reaction 
mixture was heated at 80 °C for 16 h. After allowing the 
reaction mixture to cool to room temperature, the pH was raised 
to 10.0 by the addition of dilute NaOH(aq). The resulting 
solution was stirred for 1 h causing excess Eu(III) to precipitate 
as Eu(OH)3, which was removed by filtration. The pH of the 
resulting solution was restored to 5.5 by the addition of dilute 
HCl(aq) and the solvent lypohilised to give the crude product. 
The crude product was taken in to CH2Cl2 : CH3OH (8 : 2, 
2 mL) and the solution filtered to facilitate the removal of salts. 
Subsequent removal of solvent under reduced pressure yielded 
an off-white solid which was further purified by column 
chromatography on silica gel (CH2Cl2 : CH3OH : NH3(aq), 80 : 
20 : 1) to give the title compound as an off-white solid (17 mg, 
50 %).  
δH (400 MHz, CD3OD) 10.56, 8.50, 7.76, 7.61, 7.38, 7.28, 
7.17, 7.07, 6.68, 6.29, 5.33, 4.60, 4.30, 2.98, 2.17, 1.44, 1.31, 
0.82, 0.42, -0.11, -0.37, -1.75, -1.88, -2.33, -2.87, -4.18, -
5.82, -6.20. δP (162 MHz, CD3OD) 44.5, 40.2, 34.9. m/z 
(HRMS+) 875.1659 [M + H]+ (C34H43N6O6P3151Eu requires 
875.1656). R f  = 0.16 (silica, CH2Cl2 : CH3OH : NH3(aq) 80 : 
20 : 1). Chiral HPLC (ChiralPAK-ID 4.0 mm × 250 mm, 
CH3OH, 1 mL/min, 290 K): R t  = 6.1 min. 
 
COMPLEX [EUL6-R-H] was prepared in analogous manner to 
[EuL6-S-H], using the tri-ethyl ester of L6-R-H (34 mg, 0.04 
mmol). The crude material was purified by column 
chromatography on silica gel (CH2Cl2 : CH3OH : NH3, 
80:20:1) to give the title compound as an off-white solid (27 
mg, 73 %). NMR and MS data were in agreement with the 
enantiomer [EuL6-S-H]. Chiral HPLC (ChiralPAK-ID 4.0 mm × 
250 mm, CH3OH, 1 mL/min, 290 K): R t = 10.9 min. 
 
COMPLEX [EUL6-S-BR]. The tri-ethyl ester of L6-S-Br (26 mg, 
0.025 mmol) was dissolved in CD3OD (2.4 mL) and a solution 
of 0.1 M NaOH in D2O (2.2 mL) was added. The reaction 
mixture was heated for 5 h at 90 oC with stirring. Subsequent 
removal of the solvent under reduced pressure yielded the 
deprotected ligand as a white solid (as verified by ESMS and 
31P NMR). 
The ligand was dissolved in H2O : CH3OH (4 : 1, 1.5 mL) and 
the pH of the solution adjusted to 5.5 using dilute HBr(aq). 
Eu(NO3)3.5H2O (12 mg, 0.027 mmol) was added and the 
reaction mixture was heated at 80 °C for 16 h. After allowing 
the reaction mixture to cool to RT, the pH was raised to 10.0 by 
the addition of dilute NaOH(aq). The resulting solution was 
stirred for 1 h causing excess Eu(III) to precipitate as Eu(OH)3, 
which was removed by filtration. The pH of the resulting 
solution was restored to 5.5 by the addition of dilute HBr(aq) 
and the solvent lypohilised to give the crude product. The crude 
product was taken in to CH2Cl2 : CH3OH (8 : 2, 2 mL) and the 
solution filtered to facilitate the removal of salts. Subsequent 
removal of solvent under reduced pressure yielded an off-white 
solid which was further purified by column chromatography on 
silica gel (CH2Cl2 : CH3OH : NH3(aq), 80 : 20 : 1) to give the 
title compound as an off-white solid (21 mg, 76 %).  
δH (400 MHz, CD3OD) 10.87, 9.23, 8.51, 7.89, 7.16, 7.25, 
7.48, 7.52, 6.16, 5.09, 4.48, 4.24, 2.85, 2.52, 1.87, 1.30, 1.47, 
0.52, -0.34, -0.70, -2.23, -2.38, -2.49, -2.76, -3.11, -4.54, -6.03, 
-6.46. δP (162 MHz, CD3OD) 43.9, 40.2, 33.5. m/z (HRMS+) 
1113.9153 [M + H]+ (C34H40N6O6P379Br3151Eu requires 
1113.9031). R f  = 0.56 (silica, CH2Cl2 : CH3OH : NH3(aq) 80 : 
20 : 1). Chiral HPLC (ChiralPAK-ID 4.0 mm × 250 mm, 
CH3OH, 1 mL/min, 290 K): R t  = 11.6 min. 
 
COMPLEX [EUL7] was prepared in analogous manner to 
[EuL3], using the tri-ethyl ester of L7 (10 mg, 8.8 µmol). The 
crude material was purified by column chromatography (silica, 
CH2Cl2 : CH3OH : NH3(aq) 90:10:1) to give the title compound 
as a white solid (3 mg, 30 %). 
δH (400 MHz, CD3OD) 10.13, 9.08, 8.57, 7.95, 7.85, 7.36, 
7.20, 6.66, 6.24, 5.69, 3.10, 2.29, 2.19, 2.03, 1.80, 1.53, 1.37, 
1.02, 0.68, -0.28, -0.60, -0.75, -1.71, -2.15, -2.38, -2.61, -
4.91, -5.65, -6.01. δP (162 MHz, CD3OD) 43.4, 40.7, 37.5. m/z 
(HRMS+) 1203.9955 [M + H]+ (C38H53N7O7P379Br3 151Eu 
requires 1203.9950). R f  = 0.32 (silica, CH2Cl2 : CH3OH : 
NH3(aq) 90 : 10 : 1). Chiral HPLC (ChiralPAK-ID 4.0 mm × 
250 mm, CH3OH, 1 mL/min, 290 K): R t = 14.5 min. 
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COMPLEX [EUL8] (as a racemate) has been prepared within our 
laboratories previously.12 A sample of [EuL8] was resolved 
using a semi-prep CHIRAL-PAK IC column. Chiral HPLC 
(ChiralPAK-IC 4.0 mm × 250 mm, CH3OH, 0.5 mL/min, 
290  K): R t  = 11.7 min & 19.8 min. 
 
COMPLEX [EUL9] was prepared in an analogous manner to 
[EuL3], using the tri-methyl ester of L9 (18 mg, 0.031 mmol). 
The crude material was purified by column chromatography 
(silica, CH2Cl2 : CH3OH : NH3 80 : 20 : 0.1), to obtain the title 
compound as a white solid (16 mg, 76 %). 
δH (400 MHz, D2O) 7.95, 7.09, 6.79, 6.46, 5.85, 5.61, 5.44, 
5.07, 4.65, 4.34, 4.04, 2.77, 2.74, 2.57, 2.35, 1.63, 
1.06, -0.53, -0.87, -1.47, -4.58, -5.13, -5.53. m/z (HRMS+) 
697.1415 [M + H]+ (C28H30N6O6151Eu requires 697.1425). R f  
= 0.23 (silica, CH2Cl2 : CH3OH : NH3 72:15:3). Due to the 
partial racemisation of the chiral centre (see ESI†), a sample of 
the complex was submitted to chiral HPLC using a semi-prep 
CHIRALPAK-IC column to separate the two enantiomers. 
Chiral HPLC (ChiralPAK-IC 4.0 mm × 250 mm, CH3OH, 0.5 
mL/min, 298 K): R t  = (12.3 min &) 19.7 min. 
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